Total (all‐cause) mortality · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… showed no clear difference in total (all‐cause) mortality compared with placebo/no antifungal/any other antifungal (moderate certainty).
1 finding from 1 review
Proven invasive fungal infection · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… may leads to lower proven invasive fungal infection compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Superficial fungal infection · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… showed no clear difference in superficial fungal infection compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Fungal colonization · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… may leads to lower fungal colonization compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Treatment cessation due to adverse events · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… showed no clear difference in adverse events requiring cessation of study drug(s) compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Intervention not reported
Overall mortality · treating infections in people with neutropenia or neutrophil dysfunction
It is very uncertain whether the intervention changes overall mortality (very low certainty).
1 finding from 1 review
Intervention not reported
Clinical response to infection · treating infections in people with neutropenia or neutrophil dysfunction
The intervention showed no clear difference in clinical response to infection (low certainty).
1 finding from 1 review
Intervention not reported
Length of time with fever ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of days on therapeutic antibiotics ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of serious adverse events ‐ pulmonary · treating infections in people with neutropenia or neutrophil dysfunction
It is very uncertain whether the intervention changes number of serious adverse events ‐ pulmonary (very low certainty).
1 finding from 1 review
Intervention not reported
Number of adverse events requiring discontinuation of treatment ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term mortality · gastric cancer
Laparoscopic gastrectomy showed no clear difference in short‐term mortality compared with open gastrectomy (low certainty).
1 finding from 1 review
All‐cause mortality at maximal · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes long‐term mortality (maximal compared with open gastrectomy (very low certainty).
1 finding from 1 review
Proportion with a serious adverse event (< 3 months) · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes proportion with a serious adverse event (< 3 months) compared with open gastrectomy (very low certainty).
1 finding from 1 review
Long‐term recurrence (maximal · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes long‐term recurrence (maximal compared with open gastrectomy (very low certainty).
1 finding from 1 review
Proportion with an adverse event (< 3 months) · gastric cancer
It is very uncertain whether laparoscopic gastrectomy changes proportion with an adverse event (< 3 months) compared with open gastrectomy (very low certainty).
1 finding from 1 review
Quantity of perioperative blood transfused · gastric cancer
1 finding from 1 review
Length of hospital stay · gastric cancer
1 finding from 1 review
Lymph nodes retrieved · gastric cancer
1 finding from 1 review